Growing numbers of people in Ireland are taking the risk of going online to illegally secure supplies of weight-loss jabs like Ozempic, putting themselves in danger from fake medicines, a watchdog ...

More than 1,400 units of products bought online that claim to be weight loss medications have been seized by authorities so ...

HPRA warns of risks of illegal, counterfeit versions of drugs such as Ozempic and Wegovy, saying they pose ‘significant risk’ ...

The HPRA has issued a serious warning to the public about the dangers of buying GLP-1 medicines, such as semaglutide.

The ABC7 Chicago I-Team and ABC News are investigating the risks, and finding out how people are safely getting lower-cost ...

Lilly’s spokeswoman points out that the company is broadening access and affordability by offering Zepbound single-dose vials through ... FDA-approved tirzepatide medications are available ...

Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, reduced the risk of worsening heart failure events by 38% in adults ...

Eli Lilly's tirzepatide cut cardiovascular mortality and heart failure event risk by 38% in HFpEF patients over a two-year median follow-up. Patients on tirzepatide showed a 56% reduction in heart ...

New medication that can cut body weight by 23% could radically reduce the number of people who are obese. Tirzepatide is ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the FDA. Detailed results were announced from a phase 3 clinical trial evaluating ...

Tirzepatide is a long-acting agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, approved by the U.S. Food and Drug Administration for ...